Previous 10 | Next 10 |
Hamilton, Bermuda, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that it has obtained...
The USPTO has issued a notice of allowance to Auris Medical Holding's (NASDAQ: EARS ) patent application entitled “Pharmaceutical Composition Comprising Betahistine” (U.S. Patent Application No. 15/887,388). More news on: Auris Medical Holding Ltd., Healthcare stocks news, ...
Hamilton, Bermuda, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that the United Stat...
Hamilton, Bermuda, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced the appointment of E...
Hamilton, Bermuda, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced the formation of a Sc...
Auris Medical Holding Ltd. (EARS) Q2 2019 Results Earnings Conference Call August 15, 2019, 08:00 AM ET Company Participants Thomas Meyer - CEO Hernan Levett - CFO Conference Call Participants Presentation Operator Good morning, and welcome to Auris Medical's Conferen...
Auris Medical (NASDAQ: EARS ): 1H GAAP EPS of -CHF1.66. More news on: Auris Medical Holding Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
Hamilton, Bermuda, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Enrollment of first patient in TRAVERS Phase 2 trial with AM-125 in acute vertigo Enrollment completed in Phase 1b trial with AM-201 in antipsychotic-induced weight gain Relocation to Bermuda to gain corporate flexibility, reduce co...
Sigma Labs (NASDAQ: SGLB ) +19% to work with airbus to deploy PrintRite3D rapid test and evaluation program More news on: Sigma Labs, Inc., Valeritas Holdings, Inc., RingCentral, Inc., Stocks on the move, Read more ...
Hamilton, Bermuda, July 30, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that the first patien...
News, Short Squeeze, Breakout and More Instantly...
Auris Medical Holding AG Company Name:
EARS Stock Symbol:
NASDAQ Market:
LAS VEGAS, NV - ( NewMediaWire ) - April 04, 2022 - Digipath, Inc. (OTCQB: DIGP) (“Digipath” or the “Company”), a service-oriented independent analytical testing laboratory, data analytics firm focused on the cannabis and hemp markets is pleased to annou...
Hamilton, Bermuda, July 15, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today announced the launch of its newly-designed corporate...
Are These Reddit Penny Stocks on Your Watchlist in 2021? Reddit penny stocks have become commonplace talking points in the stock market over the past year and a half. While the clear reason for this is heightened interest in the stock market, there are a couple of other reasons to consi...